Acumen Pharmaceuticals, Inc.

ABOS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K Sep 16, 2026 8-K
S-8 Aug 12, 2026 S-8
10-Q Aug 12, 2026 10-Q
8-K Aug 12, 2026 8-K
4 Jun 17, 2026 FORM 4
144 Jun 17, 2026
144 Jun 16, 2026
8-K Jun 16, 2026 8-K
144 Jun 15, 2026
4 Jun 10, 2026 FORM 4
144 Jun 9, 2026
4 Jun 5, 2026
4 Jun 5, 2026 FORM 4
4 Jun 5, 2026 FORM 4
4 Jun 5, 2026 FORM 4
4 Jun 5, 2026 FORM 4
4 Jun 5, 2026 FORM 4
4 Jun 5, 2026 FORM 4
4 Jun 5, 2026 FORM 4
8-K Jun 3, 2026 8-K
10-Q May 12, 2026 10-Q
8-K May 12, 2026 8-K
ARS Apr 23, 2026 ARS
DEFA14A Apr 23, 2026 DEFA14A
DEF 14A Apr 23, 2026 DEF 14A
← Newer Page 1 of 15 · 358 filings Older →